Cargando…

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review

18F-fluorodeoxyglucose positron emission tomography with integrated computed tomography (FDG-PET/CT) and contrast-enhanced computed tomography (CT) can be used for response evaluation in metastatic breast cancer (MBC). In this study, we aimed to review literature comparing the PET Response Criteria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helland, Fredrik, Hallin Henriksen, Martine, Gerke, Oke, Vogsen, Marianne, Høilund-Carlsen, Poul Flemming, Hildebrandt, Malene Grubbe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787711/ https://www.ncbi.nlm.nih.gov/pubmed/31461923 http://dx.doi.org/10.3390/diagnostics9030106

Ejemplares similares

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond
por: Hildebrandt, Malene Grubbe, et al.
Publicado: (2019)

Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy
por: Hansen, Jeanette Ansholm, et al.
Publicado: (2021)

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST
por: Vogsen, Marianne, et al.
Publicado: (2021)

Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer
por: Baun, Christina, et al.
Publicado: (2018)

Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2021)

Prognostic Value of Dual-Time-Point (18)F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2020)

Cost-effectiveness of 2-[(18)F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)

The Pattern of Metastatic Breast Cancer: A Prospective Head-to-Head Comparison of [(18)F]FDG-PET/CT and CE-CT
por: Gram-Nielsen, Rosa, et al.
Publicado: (2023)

Perspective of Patients With Metastatic Breast Cancer on Electronic Access to Scan Results: Mixed Methods Study
por: Baun, Christina, et al.
Publicado: (2020)

2-[(18)F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer
por: Vogsen, Marianne, et al.
Publicado: (2023)

(18)F-FDG PET/CT for detection of the primary tumor in adults with extracervical metastases from cancer of unknown primary: A systematic review and meta-analysis
por: Burglin, Synne Alexandra, et al.
Publicado: (2017)

Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study
por: Vogsen, Marianne, et al.
Publicado: (2021)

Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
por: Gerke, Oke, et al.
Publicado: (2017)

Comparison of Image Quality and Quantification Parameters between Q.Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)

Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer
por: Sørensen, Jonas S., et al.
Publicado: (2020)

A prospective study on dual time (18)F-FDG-PET/CT in high-risk prostate cancer patients
por: Mortensen, Mike Allan, et al.
Publicado: (2018)

Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer
por: Holm, Jorun, et al.
Publicado: (2020)

Prevalence of focal incidental breast uptake on FDG-PET/CT and risk of malignancy: a systematic review and meta-analysis
por: Aarstad, Else Marie, et al.
Publicado: (2019)

Learning from patient involvement in a clinical study analyzing PET/CT in women with advanced breast cancer
por: Vogsen, Marianne, et al.
Publicado: (2020)

PET/CT without capacity limitations: a Danish experience from a European perspective
por: Høilund-Carlsen, Poul Flemming, et al.
Publicado: (2011)

Role of FDG-PET/CT in Assessing the Correlation Between Blood Pressure and Myocardial Metabolic Uptake
por: Rojulpote, Chaitanya, et al.
Publicado: (2020)

2-[18F]FDG-PET/CT in Cancer of Unknown Primary Tumor—A Retrospective Register-Based Cohort Study
por: Rimer, Heidi, et al.
Publicado: (2023)

Common carotid segmentation in (18)F‐sodium fluoride PET/CT scans: Head‐to‐head comparison of artificial intelligence‐based and manual method
por: Piri, Reza, et al.
Publicado: (2022)

Fusion and Healing Prediction in Posterolateral Spinal Fusion Using (18)F-Sodium Fluoride-PET/CT
por: Constantinescu, Caius M., et al.
Publicado: (2020)

PET/CT imaging of spinal inflammation and microcalcification in patients with low back pain: A pilot study on the quantification by artificial intelligence‐based segmentation
por: Piri, Reza, et al.
Publicado: (2022)

How to assess intra- and inter-observer agreement with quantitative PET using variance component analysis: a proposal for standardisation
por: Gerke, Oke, et al.
Publicado: (2016)

Atherosclerosis imaging with (18)F-sodium fluoride PET: state-of-the-art review
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2019)

FDG PET/CT in cancer: comparison of actual use with literature-based recommendations
por: Petersen, Henrik, et al.
Publicado: (2015)

Sacroiliac Joint Asymmetry Regarding Inflammation and Bone Turnover: Assessment by FDG and NaF PET/CT
por: Al-Zaghal, Abdullah, et al.
Publicado: (2019)

Low-Dose Radiation to COVID-19 Patients to Ease the Disease Course and Reduce the Need of Intensive Care
por: Høilund-Carlsen, Poul Flemming, et al.
Publicado: (2020)

Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not
por: Alavi, Abass, et al.
Publicado: (2022)

Aging and Cerebral Glucose Metabolism: (18)F-FDG-PET/CT Reveals Distinct Global and Regional Metabolic Changes in Healthy Patients
por: Subtirelu, Robert Christopher, et al.
Publicado: (2023)

A randomised trial of [(18)F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol
por: Buch‐Olsen, Karen Middelbo, et al.
Publicado: (2023)

FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

NaF-PET Imaging of Atherosclerosis Burden
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Atherosclerosis Imaging with (18)F-Sodium Fluoride PET
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2020)

(18)F-Fluoromethylcholine-positron emission tomography/computed tomography for diagnosing bone and lymph node metastases in patients with intermediate- or high-risk prostate cancer
por: Mortensen, Mike Allan, et al.
Publicado: (2019)

Atherosclerosis Burdens in Diabetes Mellitus: Assessment by PET Imaging
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

Cisplatin-Resistant CD44(+) Lung Cancer Cells Are Sensitive to Auger Electrons
por: Madsen, Karina Lindbøg, et al.
Publicado: (2022)

Bilateral Carotid Artery Molecular Calcification Assessed by [(18)F] Fluoride PET/CT: Correlation with Cardiovascular and Thromboembolic Risk Factors
por: Patil, Shiv, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7cp6i2tr3hagkl32g8mgsoifeq